<--- Back to Details
First PageDocument Content
Malaria / Vaccines / PfSPZ vaccine / Malaria vaccine / Plasmodium falciparum / PATH / Marathon Oil / Sanaria / Equatorial Guinea / RTS / S / Manuel Elkin Patarroyo
Date: 2015-06-30 10:26:56
Malaria
Vaccines
PfSPZ vaccine
Malaria vaccine
Plasmodium falciparum
PATH
Marathon Oil
Sanaria
Equatorial Guinea
RTS
S
Manuel Elkin Patarroyo

GOVERNMENT OF EQUATORIAL GUINEA AND OIL COMPANIES AGREE TO $48.5 MILLION FUNDING OF MALARIA VACCINE DEVELOPMENT PROGRAM WITH SANARIA INC. ROCKVILLE, MD – 29 JuneFor immediate release – The Government of the Re

Add to Reading List

Source URL: www.sanaria.com

Download Document from Source Website

File Size: 71,63 KB

Share Document on Facebook

Similar Documents

Frequently asked questions (FAQs) RIA2018SV- Strategic action for the comparison, selection and development of malaria vaccine candidates Document history Version

Frequently asked questions (FAQs) RIA2018SV- Strategic action for the comparison, selection and development of malaria vaccine candidates Document history Version

DocID: 1v2j2 - View Document

1  1 RTS,S/AS01 MALARIA VACCINE CANDIDATE PHASE III SAFETY EVALUATION IN AFRICAN INFANTS 6-12 WEEKS OF AGE AT FIRST VACCINATION OVER FOURTEEN MONTHS OF

1 1 RTS,S/AS01 MALARIA VACCINE CANDIDATE PHASE III SAFETY EVALUATION IN AFRICAN INFANTS 6-12 WEEKS OF AGE AT FIRST VACCINATION OVER FOURTEEN MONTHS OF

DocID: 1uoQf - View Document

ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL

ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL

DocID: 1tPZr - View Document

Science article: “Protection Against Malaria by Intravenous Immunization with a Non-Replicating Sporozoite Vaccine” What: A phase 1 clinical trial of Sanaria’s malaria vaccine, the Sanaria PfSPZ Vaccine, demonstrat

Science article: “Protection Against Malaria by Intravenous Immunization with a Non-Replicating Sporozoite Vaccine” What: A phase 1 clinical trial of Sanaria’s malaria vaccine, the Sanaria PfSPZ Vaccine, demonstrat

DocID: 1suvJ - View Document

Sanaria Inc. to launch crowdfunding campaign for SporoBotTM, a mosquito-dissecting robot for accelerating manufacture of Sanaria’s malaria vaccine. ROCKVILLE, MD – April 30, 2014 – For immediate release - Biotechno

Sanaria Inc. to launch crowdfunding campaign for SporoBotTM, a mosquito-dissecting robot for accelerating manufacture of Sanaria’s malaria vaccine. ROCKVILLE, MD – April 30, 2014 – For immediate release - Biotechno

DocID: 1sjTZ - View Document